Checkpoint-Inhibitors Archive - Seite 5 von 6 - IOZK

Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma

2017-01-01/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Multiple Myeloma

PD-1 blockade enhances the vaccination-induced immune response in glioma

2016-07-07/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

2016-06-21/in Checkpoint-Inhibitors, International Publications

Emerging immunotherapies for glioblastoma

2016-06-01/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade

2016-01-06/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors

2015-09-01/in Checkpoint-Inhibitors, International Publications

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy

2015-06-02/in Breast Cancer, Checkpoint-Inhibitors, Dendritic Cells, International Publications

Classifying Cancers Based on T-cell Infiltration and PD-L1

2015-06-01/in Checkpoint-Inhibitors, International Publications

Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential

2015-04-09/in Checkpoint-Inhibitors, International Publications

Clinical use of dendritic cells for cancer therapy

2014-06-01/in Checkpoint-Inhibitors, Dendritic Cells, International Publications